Thu. Feb 6th, 2025

Moderna Drops on Plans to Cut R&D Costs

Moderna Inc. shares fell 7.5% in extended trading on Tuesday, after the biotech company announced plans to cut research and development costs by about 20% to $3.2 billion this year. The company said it would achieve the savings through a restructuring plan that includes reducing headcount and streamlining its operations.

By admin

Related Post